Warsaw, Poland

Andrzej Piasek


 

Average Co-Inventor Count = 8.5

ph-index = 1

Forward Citations = 7(Granted Patents)


Company Filing History:


Years Active: 2012-2015

Loading Chart...
Loading Chart...
2 patents (USPTO):Explore Patents

Title: Innovations and Contributions of Andrzej Piasek

Introduction

Andrzej Piasek is a notable inventor based in Warsaw, Poland. He has made significant contributions to the field of pharmaceuticals, particularly in the development of nucleotide analogues and their applications in antiviral treatments. With a total of two patents to his name, his work has implications for the treatment of serious viral infections.

Latest Patents

Piasek's latest patents include a nucleotide analogue, a method of synthesis of this analogue, and its use in antiviral applications. One of his notable inventions is a pharmaceutical composition that includes nucleotide analogues and antiviral pro-nucleotides, which are useful in inhibiting the human immunodeficiency virus (HIV). The invention is expressed in a specific formula where X stands for N and B stands for thymidine-1-yl, or X stands for H and B stands for uracil-1-yl, adenin-1-yl, or hypoxanthin-1-yl. Additionally, he has developed a method for synthesizing the nucleotide analogue using a phosphorylating agent. Another significant patent involves derivatives of epirubicin, which are aimed at treating hepatitis C virus (HCV).

Career Highlights

Throughout his career, Andrzej Piasek has worked with esteemed institutions such as the Institute of Bioorganic Chemistry and the National Institute of Medicines. His research has focused on the medicinal applications of his inventions, contributing to advancements in pharmaceutical science.

Collaborations

Piasek has collaborated with notable colleagues, including Andrzej Lipniacki and Adam Kraszewski. Their joint efforts have furthered research in the field of antiviral medications and drug development.

Conclusion

Andrzej Piasek's innovative work in the field of pharmaceuticals, particularly with nucleotide analogues and their applications, showcases his significant contributions to medical science. His patents reflect a commitment to advancing treatments for viral infections, making a lasting impact in the industry.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…